Lupus Nephritis: all 338 studies
Page 4 of 4. Open to participants first (131), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus NephritisWithdrawnNCT01288664Phase 3
- An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus NephritisCompletedNCT01273389Phase 2
- Efficacy and Safety of Tamibarotene(AM80) for Lupus NephritisStatus unknownNCT01226147Phase 2
- Tacrolimus Versus Cyclophosphamide as Treatment for Lupus NephritisCompletedNCT01207297Phase 1
- Long-Acting Tacrolimus for the Treatment of Resistant Lupus NephritisCompletedNCT01206569Phase 4
- Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus NephritisCompletedNCT01203709Phase 4
- Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus NephritisStatus unknownNCT01172002Not applicable
- Velcade for Proliferative Lupus NephritisWithdrawnNCT01169857Phase 4
- Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus NephritisCompletedNCT01056237Not applicable
- Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus NephritisCompletedNCT01042457Phase 3
- The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus NephritisTerminatedNCT01015456Phase 3
- Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune StudyCompletedNCT00976300Phase 2
- Prospective Study of TW in the Treatment of LN Type V With Gross ProteinuriaCompletedNCT00935389Not applicable
- Open Label Pilot Trial of Rituximab in Lupus Membranous NephritisWithdrawnNCT00908986Not applicable
- To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus NephritisCompletedNCT00881309Not applicable
- Assess the Efficacy and Safety of Multi-target Therapy in Lupus NephritisCompletedNCT00876616Not applicable
- Effect of Mesenchymal Stem Cell Transplantation for Lupus NephritisStatus unknownNCT00659217Phase 1/2
- Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus NephritisCompletedNCT00615173Phase 3
- A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus NephritisStatus unknownNCT00569101Phase 2
- Steroids in the Maintenance of Remission of Proliferative Lupus NephritisWithdrawnNCT00539799Phase 3
- The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent ProteinuriaWithdrawnNCT00508898Phase 4
- Cyclophosphamide in Lupus NephritisStatus unknownNCT00441220
- Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative StudyCompletedNCT00429377Phase 3
- A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus NephritisCompletedNCT00404794Phase 3
- A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970gWithdrawnNCT00404157Phase 3
- Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus NephritisCompletedNCT00371319Phase 4
- TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )TerminatedNCT00368264Phase 2/3
- Lupus Nephritis: Role of Environmental and Occupational ExposuresCompletedNCT00342329
- To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LNCompletedNCT00302549Not applicable
- Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)CompletedNCT00298506Not applicable
- Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With PrednisoneCompletedNCT00268567Phase 2/3
- Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.CompletedNCT00204022Phase 3
- Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous NephritisCompletedNCT00125307Phase 4
- Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)CompletedNCT00094380Phase 1/2
- Study of LJP 394 in Lupus Patients With History of Renal DiseaseTerminatedNCT00089804Phase 3
- Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney DiseaseCompletedNCT00035308Phase 3
- BG9588 (Anti-CD40L Antibody) to Treat Lupus NephritisCompletedNCT00001789Phase 2
- Cyclophosphamide and Fludarabine to Treat Lupus NephritisCompletedNCT00001676Phase 1